Echinacea
- Generic Name
- Echinacea
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- 4N9P6CC1DX
- Associated Conditions
- -
- Associated Therapies
- -
Impact of Echinacea as Prophilaxis for Upper Respiratory Tract Infections in Children 1-5 Years
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-07-19
- Last Posted Date
- 2011-07-22
- Lead Sponsor
- Hormozgan University of Medical Sciences
- Target Recruit Count
- 100
- Registration Number
- NCT01396889
- Locations
- 🇮🇷
Hormozgan University of Medical Sciences (HUMS), Bandar Abbas, Hormozgan, Iran, Islamic Republic of
Drug Interactions Between Echinacea Purpurea and Darunavir/Ritonavir
- First Posted Date
- 2010-01-12
- Last Posted Date
- 2019-12-04
- Lead Sponsor
- Germans Trias i Pujol Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT01046890
- Locations
- 🇪🇸
Lluita contra la Sida Foundation, HIV Unit, Irsi Caixa Foundation, Badalona, Spain
Echinacea Safety Study
- First Posted Date
- 2009-12-01
- Last Posted Date
- 2014-07-23
- Lead Sponsor
- A. Vogel AG
- Target Recruit Count
- 757
- Registration Number
- NCT01021995
- Locations
- 🇬🇧
Cardiff School of Biosciences, Cardiff, Wales, United Kingdom
Evaluation of Echinacea for the Common Cold
Phase 2
Completed
- Conditions
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Charlottesville, Virginia, United States
A Trial of Echinacea in Children
Phase 3
Completed
- Conditions
- First Posted Date
- 2002-01-10
- Last Posted Date
- 2006-08-18
- Target Recruit Count
- 600
- Registration Number
- NCT00029211
- Locations
- 🇺🇸
Child Health Institute, University of Washington, Seattle, Washington, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath